Next Article in Journal
Hematological Profile of Patients with Clostridioides difficile Infection: Clinical and Prognostic Implications
Previous Article in Journal
Clinical Reliability of Large Language Models in Complex Haematology: A Multidimensional Evaluation in Hemophilia–Oncology
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pattern of Reported Infections Among Paediatric Patients with Sickle Cell Disease: A Single-Centre Cohort Study in Nigeria

1
Department of Haematology & Blood Transfusion, Ahmadu Bello University Teaching Hospital, P.M.B. 06, Zaria 810001, Nigeria
2
Faculty of Basic Clinical Sciences, College of Medicine, Ahmadu Bello University, P.M.B. 06, Zaria 810001, Nigeria
3
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70124 Bari, Italy
4
Department of Paediatrics, Ahmadu Bello University Teaching Hospital, P.M.B. 06, Zaria 810001, Nigeria
5
College of Nursing, Ahmadu Bello University Teaching Hospital, P.M.B. 06, Zaria 810001, Nigeria
6
Antiretroviral Therapy Laboratory, Ahmadu Bello University Teaching Hospital, P.M.B. 06, Zaria 810001, Nigeria
7
Department of Medical Laboratory Science, Faculty of Allied Health Science, College of Medical Sciences, Ahmadu Bello University, P.M.B. 06, Zaria 810001, Nigeria
8
Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK
9
Faculty of Life Sciences and Medicine, King’s College, London SE1 7EH, UK
10
Novo Nordisk plc, 2880 Bagsvaerd, Denmark
*
Authors to whom correspondence should be addressed.
Hemato 2026, 7(2), 11; https://doi.org/10.3390/hemato7020011
Submission received: 19 December 2025 / Revised: 23 March 2026 / Accepted: 26 March 2026 / Published: 1 April 2026
(This article belongs to the Section Non Neoplastic Blood Disorders)

Abstract

Background: Sickle cell disease (SCD) patients have increased susceptibility to infections, particularly encapsulated bacterial pathogens such as Streptococcus pneumoniae and Haemophilus influenzae type b. Hyposplenism as well as immune defects in SCD result in increased risks for infections; these are the most frequent complications in individuals with SCD. This study was performed within the African Research and Innovative initiative for Sickle cell Education (ARISE, EC GA No 824021) project to develop best practices in the clinical management of SCD. In this retrospective study we aimed to determine the most prevalent reported infections among SCD patients’ records during clinic visits at Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Methods: The medical records of 1961 paediatric SCD patients from 1998 to 2023 were extracted and reviewed from a pilot electronic registry using a structural query. The data analysed patterns of infections reported during clinic visits at the ABUTH, Zaria, Nigeria. Results: 458 subjects (23.4%) manifesting at least one infection, of whom 392 (19.9%) subjects had a single infection (bacterial or parasitic) and 173 (8.8%) had more than one infection (bacterial and parasitic). Conclusions: Bacterial and parasitic infections are a significant complication of SCD patients attending a tertiary institution in northern Nigeria.

1. Introduction

Sickle cell disease (SCD) patients have increased susceptibility to infections due to immune deficiencies, functional asplenia, tissue infarction and impaired adaptive immune response and functional asplenia from an early age [1,2]. These infections, especially due to bacterial organisms, are the most frequent complications in individuals with SCD, leading to increased morbidity and mortality. Encapsulated bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae type b (Hib) is of special interest in SCD [3,4,5].
Pneumococcus infections account for 50–70% of bacterial infections in children under the age of 5, most of the remaining ones being accounted for by Neisseria meningitidis, Haemophilus influenza, and, to a lesser extent, Escherichia coli [6,7]. Salmonella infection does not have any specificity by age group, but a linear increase in incidence with increasing age is noted [6]. Klebsiella spp. and Escherichia coli mostly have incidence after 10 years and primarily after 20 years [6].
Malaria has a detrimental effect on homozygous SCD, resulting in higher morbidity and mortality when compared to persons without SCD [7,8,9]. Other parasitic infections are prevalent in patients with SCD, as confirmed in a Nigerian study conducted on 100 SCD patients; 27% of SCD patients had reported as having parasitic infections [10].
The routine immunisation schedule in Nigeria, based on the National Programme on Immunisation (NPI), starts at birth with BCG (Tuberculosis), Oral Polio Vaccine (OPV 0), and Hepatitis B, followed by key doses at 6, 10, and 14 weeks (Pentavalent, OPV, Pneumococcal/PCV, Rotavirus). Measles and Yellow Fever are given at 9 months [11].
In addition to the standard vaccination programme, SCD requires a series of additional vaccines, such as the annual flu shot, pneumococcal (PCV13 and PPSV23), meningococcal (ACWY and B) and Haemophilus influenza type b (Hib), to specifically counter their elevated infection risks due to functional asplenia and transfusion-related vulnerabilities [12]. A recent multicentre study confirmed pneumococcal vaccines are seldom offered routinely, and only 5.5% of SCD children in Port Harcourt had received pneumococcal vaccination, largely owing to cost, awareness, and availability barriers [13].
The main objective of this analysis is to report on the infection pattern of a subset of paediatric SCD patients in a clinical centre (Ahmadu Bello Teaching Hospital, ABUTH) at Zaria, North-Western Nigeria. The following aspects were described as well: infection rates and immunisation, association between infections’ occurrence and age, and co-occurrence of infections.

2. Materials and Methods

This was a retrospective study using hospital records of clinic visits of patients with SCD from 1998 to 2023. Using a pilot Paediatric Electronic Registry (PER) developed using Microsoft Access (MS) in 2024 [14], about 65% of patients’ last clinic visit hard copy records transferred to the PER were queried. The relevant information was extracted on the reported patterns of infections based on laboratory confirmation and clinical suspicion using MS structural query searching.

2.1. Study Site

The study was conducted in Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, North-Western Nigeria. ABUTH is a federal government-owned tertiary-level hospital with a 750-bed capacity and 17 clinical departments with over 3000 paediatric patients with SCD. The consultant-led paediatric clinic runs weekly for SCD patients aged 0 months to 18 years.
Records of 1961 patients (65% out of the total patients) were retrieved during the pilot paediatric electronic registry already reported in a previous publication by the authors [14].

2.2. Study Period

The study was conducted over a 6-month period from 1 May 2024 to 30 October 2024 on the records generated over a period of 25 years.

2.3. Data Summary and Analysis

Information on infections was reported as included by the reference physician at the time of the visit and was part of the paper records. All the paper records were transferred to the pilot registry. In case of doubt interpretation, advice was requested from an expert from the paediatric SCD clinic. Records without information about bacterial or parasitic infection were excluded. The datasets were demographics, Hb electrophoretic patterns, records of immunisation and records of bacterial or parasitic infection.
A descriptive analysis was conducted to summarise the collected information. This included indicating relative and absolute frequencies for each of the complication using Jamovi statistical software, version 2.6.44.

2.4. Statistics

A Pearson chi-square test of association and post hoc test (standardised residuals) were performed to test the statistical significance.

2.5. Ethical Approval

Ethical approval to set up the PER was obtained from the ABUTH Health Research Ethics Committee (HREC) on 27 January 2023 (ABUTHZ/HREC/F43/2023), and a request for waiving consent on retrospective data collection was granted by the committee.

3. Results

Data of 1961 paediatric SCD patients, i.e., aged <20 years, was retrieved from the registry. Demographic characteristics are shown in Table 1a, with subjects aged <9 years old having the highest population. The most common haemoglobin phenotype among study subjects is HbSS (1476 subjects, 75,3%, Table 1b).
For both variables (age and Hb pattern), ≥10% of data were unavailable due to missing records in patients’ case folders. The pilot electronic registry was implemented to identify inconsistencies in the paper-based system but faced challenges including limited access to some folders (due to referrals), illegible handwriting, missing data, and inconsistent data entry between adult and paediatric haematologists; further details are provided in another publication by the same authors.
In our cohort there were 458 subjects (23.4%) manifesting at least one infection (bacterial or parasitic), of whom 392 (19.9%) subjects had a single infection over the study period and 173 (8.8%) had more than one infection.
The most prevalent infection among subjects with one or more infection patterns was malaria, followed by osteomyelitis, acute diarrhoeal disease, acute respiratory infection and urinary tract infection (Table 2).
The pathogens responsible for osteomyelitis, acute diarrhoeal disease, acute respiratory infection and urinary tract infection were not recorded in the patient’s case files, and only clinical diagnoses were documented.
The most common haemoglobin electrophoretic pattern among subjects with infection (n = 458) was HbSS (450 subjects, 98.3%), followed by HbSC (8 subjects, 1.7%).
Data on the occurrence of infections by age groups are reported in Table 3. The test of association indicates that the age groups 5–14 had a statistically higher infection rate compared to those >14 years (Table 4).
Only 1221 children (64.1%) had received routine immunisation (Table 4). Among children who were not immunised, a higher proportion had no infection (37.6%) compared with those who had an infection (31.6%). Conversely, among immunised children, the proportion with infection (68.4%) was higher than the proportion without infection (62.4%). This finding should be interpreted with caution, as malaria—the most common infection identified in this study—is not currently preventable through routine immunisation in Nigeria.

4. Discussion

This study reported the pattern of infection among paediatric SCD patients attending the ABUTH clinic retrospectively from a pilot paediatric electronic registry (PER) which was designed and implemented by transferring about 65% of hard-copy medical records documented at clinic visits using structural query searching of MS Access. The search revealed that only 64.1% of the SCD patients had received routine immunisation according to the Nigerian National Programme on Immunisation (NPI) routine schedule. The level of vaccination is low, as it often targets 80 to 90% of the population. It was found that malaria was the most prevalent infection, with 42.8%, perhaps because malaria is endemic in this part of the world even among non-SCD patients. This is corroborated by a study conducted in Nigeria that reported that 66% of SCD children presenting with severe anaemia had malarial infection, and the overall mortality was 8.7% [15]. Malaria has been described as the most common precipitating cause of crisis in endemic countries [16,17].
Osteomyelitis was 31.6% among the patients. Osteomyelitis was reported to occur between 0.5 and 16% in children and adults with SCD [18,19,20,21]. A total of 42–57% of acute osteomyelitis in North America is caused by Salmonella species and S. aureus [22,23]. The most common pathogens in West Africa and Saudi Arabia are said to be Salmonella species [22,24]. Salmonella typhi (the only encapsulated Salmonella species), Salmonella non-typhi species, Gram-negative enteric bacteria, and S. aureus can all cause osteomyelitis [25].
Twelve-point seven percent of the patients had acute diarrhoeal disease. Diarrhoea is a common gastrointestinal symptom in individuals with SCD [26]. The exact cause of diarrhoea in sickle cell patients can vary, but it may be related to factors like medications, infections, or the disease itself [25,27].
Acute respiratory infections affected 7.4% of individuals. Respiratory infections are a risk factor for triggering acute chest syndrome (ACS) in sickle cell anaemia patients and often lead to several complications [28]. Influenza-associated hospitalisation and complications in paediatric SCD patients were reported to be 56-times higher than in non-SCD patients [28].
Urinary tract infection (UTI) was reported in 5.5% of patients in this study, and this is in line with other findings, especially in studies conducted in the West African region. UTI prevalence in SCD patients ranges from 6 to 26% and is more common in children with SCD than healthy children [29]. A UTI is a risk factor for renal impairment, especially in SCD patients. Vaso-occlusion within the vasa rectae of the inner medulla causes ischaemia, renal infarction, papillary necrosis, and scarring of the renal medulla, which promotes UTIs [30]. Many episodes of Gram-negative septicaemia in SCD are secondary to UTI [30,31]. It was not documented in the registry whether pneumonia is one of the causes of the ACS; the most common cause of pneumonia in younger children is S. pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycoplasma hominis, and S. aureus (and, to a lesser extent, Legionella species) in older children and adults [3,30,31]. Pulmonary infection is one of the leading causes of ACS, and it is usually difficult to differentiate patients with ACS from those with pneumonia or those who have both. Of 670 ACS episodes analysed during a 4-year period, 45.7% had an unknown cause, 29.4% were attributed to infection, 16.1% to infarction, and 8.8% to fat embolism [32]. In an analysis of 292 ACS episodes in which a cause could be determined, infection was responsible for one-half of the cases, and of these, 25% were caused by a Chlamydia species, 22% were caused by Mycoplasma species, and 22% were caused by viruses [32].
Statistical analysis using a test of association (Table 3) indicates that the age groups 5–14 had a statistically higher infection rate compared to those >14 years (p < 0.001), while paradoxically, the analysis between immunisation status and infection (Table 4) shows a significant (p < 0.014) association between routine immunisation and infection. However, it should be noted that the major infection reported was malaria, which is not an immunisation-preventable disease in Nigeria at the moment.

Study Limitations

One of the principal limitations of this study pertains to missing data and the limited availability of detailed pathogen information, attributable to the nature of the original dataset and consistent with its pilot design. Nevertheless, the findings provide valuable insight into the frequency of infections among children with SCD in a Nigerian setting, where such data have not previously been available.

5. Conclusions

Infection is one of the major causes of morbidity and mortality among children with SCD, especially in developing countries where access to quality care is lower than in the developed countries. Further research is needed to determine the mechanism behind the susceptibility to infection among SCD patients, especially in Africa, where the prevalence of infectious disease is high. Preventive measures such as vaccination, good hygiene and prophylaxis need to be put in place. It is our recommendation that the implementation of early diagnosis with penicillin V prophylaxis and prompt treatment of infections like salmonella and malaria be of paramount importance.

Author Contributions

Conceptualization, M.A.I.; methodology, M.A.I. and L.R.; data curation, M.A.I.; writing—original draft preparation, M.A.I.; writing—review and editing, M.A.I., L.R., H.R.A., A.H., I.N.I., J.A.F., S.A. (Sani Awwalu), N.M.A., W.A. and B.P.D.I.; statistical analysis, R.W.; structural query searching, N.U., M.M. and S.A. (Saidu Abdulkadir); project administration and funding acquisition, F.B. and B.P.D.I. All authors have read and agreed to the published version of the manuscript.

Funding

The ARISE project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 824021. This publication reflects only the author’s view. The European Commission Research Executive Agency (REA) is not responsible for any use that may be made of the information it contains.

Institutional Review Board Statement

The PER was developed in accordance with the Declaration of Helsinki and approved by the ABUTH Ethics Committee on 27 January 2023 (ABUTHZ/HREC/F43/2023).

Informed Consent Statement

A request for waiving individual consent on retrospective data collection was granted by the committee.

Data Availability Statement

Raw data from the registry were not shared and will not be shared. Only aggregated data will be disseminated and presented as results of the study. Primary (raw) data will be available only to the study principal investigator and authorised study team members, bound by professional secrecy. Only aggregated data (e.g., cumulative data and statistics) may be made available to third parties, if requested, for specific and verified purposes (e.g., a summary of research activities, abstracts/presentations or other scientific articles).

Acknowledgments

Authors thank the management of Ahmadu Bello University (ABU), Zaria, and ABUTH for permitting the study; all doctors, nurses, medical laboratory scientists, health information officers, research assistants and people living with sickle cell disease; parents/guardians; and all the caregivers for cooperation.

Conflicts of Interest

Author B.P.D.I. has been involved as a consultant in Company Novo Nordisk plc. All the other authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ABUTHAhmadu Bello University Teaching Hospital
ACSAcute Chest Syndrome
MSMicrosoft Access
NPINational Programme on Immunisation
PERPaediatric Electronic Registry
SCDSickle Cell Disease
UTIUrinary Tract Infection

References

  1. Scourfield, L.E.A.; Nardo-Marino, A.; Williams, T.N.; Rees, D.C. Infections in sickle cell disease. Haematologica 2025, 110, 546–561. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
  2. King, H.; Shumacker, H.B. Splenic studies: I. Susceptibility to infection after splenectomy performed in infancy. Ann. Surg. 1952, 136, 239–242. [Google Scholar] [CrossRef] [Scilit]
  3. Booth, C.; Inusa, B.; Obaro, S.K. Infection in sickle cell disease: A review. Int. J. Infect. Dis. 2010, 14, e2–e12. [Google Scholar] [CrossRef] [Scilit]
  4. Brown, B.; Dada-Adegbola, H.; Trippe, C.; Olopade, O. Prevalence and etiology of bacteremia in febrile children with sickle cell disease at a Nigeria tertiary hospital. Mediterr. J. Hematol. Infect. Dis. 2017, 9, e2017039. [Google Scholar] [CrossRef] [Scilit]
  5. Di Nuzzo, D.V.; Fonseca, S.F. Anemia falciforme e infecções [Sickle cell disease and infection]. J. Pediatr. (Rio J.) 2004, 80, 347–354. [Google Scholar]
  6. Magnus, S.A.; Hambleton, I.R.; Moosdeen, F.; Serjeant, G.R. Recurrent infections in homozygous sickle cell disease. Arch. Dis. Child. 1999, 80, 537–541. [Google Scholar] [CrossRef] [Scilit]
  7. Aluoch, J.R. Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Trop. Med. Int. Health 1997, 2, 568–571. [Google Scholar] [CrossRef] [Scilit]
  8. Makani, J.; Komba, A.N.; Cox, S.E.; Oruo, J.; Mwamtemi, K.; Kitundu, J.; Magesa, P.; Rwezaula, S.; Meda, E.; Mgaya, J.; et al. Malaria in patients with sickle cell anemia: Burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood 2010, 115, 215–220. [Google Scholar] [CrossRef] [Scilit]
  9. Uyoga, S.; Macharia, A.W.; Ndila, C.M.; Nyutu, G.; Shebe, M.; Awuondo, K.O.; Mturi, N.; Peshu, N.; Tsofa, B.; Scott, J.A.G.; et al. The indirect health effects of malaria estimated from health advantages of the sickle cell trait. Nat. Commun. 2019, 10, 856. [Google Scholar] [CrossRef] [Scilit]
  10. Ahmed, S.G.; Uraka, J. Impact of intestinal parasites on haematological parameters of sickle-cell anaemia patients in Nigeria. East. Mediterr. Health J. 2011, 17, 710–713. [Google Scholar] [CrossRef] [Scilit]
  11. PAN Advisory Committee on Immunisation. Pediatric Association of Nigeria (PAN) recommended routine immunization schedule for Nigerian children. Niger. J. Pediatr. 2024, 39, 152–158. Available online: https://www.njpaediatrics.com/index.php/njp/article/view/1117 (accessed on 23 February 2026).
  12. Adamkiewicz, T.V.; Sarnaik, S.; Buchanan, G.R. Invasive pneumococcal infections in children with Sickle Cell Disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J. Pediatr. 2023, 143, 438–444. [Google Scholar] [CrossRef] [Scilit]
  13. Goerge, I.O.; Onyearugha, C.N. Pneumococcal vaccination status of children with sickle cell disease in Port Harcourt, Nigeria. Int. J. Pediatr. Res. 2017, 2, 1–3. [Google Scholar]
  14. Idris, M.A.; Ruggieri, L.; Ahmad, H.R.; Hassan, A.; Ibrahim, I.N.; Adullahi, F.J.; Awwalu, S.; Nasiru, U.; Bonifazi, F.; Inusa, B.P.D. Design and Implementation of a Sickle Cell Disease Electronic Registry in Resource Limited Setting in Nigeria—A Pilot Study. Hemato 2024, 5, 340–349. [Google Scholar] [CrossRef] [Scilit]
  15. Ambe, J.P.; Fatunde, J.O.; Sodeinde, O.O. Associated Morbidities in Children with Sickle-Cell Anaemia Presenting with Severe Anaemia in a Malarious Area. Tropical Doctor 2001, 31, 26–27. [Google Scholar] [CrossRef] [Scilit]
  16. Cannas, G.; Merazga, S.; Virot, E. Sickle cell disease and infections in high- and low-income countries. Mediterr. J. Hematol. Infect. Dis. 2019, 11, e2019042. [Google Scholar] [CrossRef] [Scilit]
  17. Ahmed, S.G.; Ibrahim, U.A. A compendium of pathophysiologic basis of etiologic risk factors for painful vaso-occlusive crisis in sickle cell disease. Niger. J. Basic Clin. Sci. 2017, 14, 57–77. [Google Scholar] [CrossRef] [Scilit]
  18. Bahebeck, J.; Atangana, R.; Techa, A.; Monny-Lobe, M.; Sosso, M.; Hoffmeyer, P. Relative rates and features of musculoskeletal complications in adult sicklers. Acta Orthop. Belg. 2004, 70, 107–111. [Google Scholar]
  19. Vaishya, R.; Agarwal, A.K.; Edomwonyi, E.O.; Vijay, V. Musculoskeletal manifestations of sickle cell disease: A review. Cureus 2015, 7, e358. [Google Scholar] [CrossRef] [Scilit]
  20. Onwubalili, J.K. Sickle cell disease and infection. J. Infect. 1983, 7, 2–20. [Google Scholar] [CrossRef] [Scilit]
  21. Alhajri, M.M.; Alwazzeh, M.J.; Almulhim, G.; Alsahlawi, A.; Alharbi, M.A.; Alotaibi, F.; Alanazi, B.S.; Alzahrani, A.S.; Aljabbari, F. Challenges and Management Outcomes of Osteoarticular Infections in Adult Sickle Cell Disease Patients. J. Clin. Med. 2025, 14, 8542. [Google Scholar] [CrossRef] [Scilit]
  22. Mallouh, A.; Talab, Y. Bone and joint infection in patients with sickle cell disease. J. Pediatr. Orthop. 1985, 5, 158–162. [Google Scholar] [CrossRef]
  23. Anand, A.J.; Glatt, A.E. Salmonella osteomyelitis and arthritis in sickle cell disease. Semin. Arthritis Rheum. 1994, 24, 211–221. [Google Scholar] [CrossRef] [Scilit]
  24. Faris, K.S.; Alrehaili, A.F.; Alsobhi, O.R.; Alenzi, A.A.; Almuhammadi, M.M.; Alerwi, F.S.; Alsuhaimi, O.O.; Almuzaini, M.M.; Faid, H.A.; Kabli, M.F. Genetic blood disorders in Saudi Arabia. Multi-Knowl. Electron. Compr. J. Educ. Sci. Publ. (MECSJ) 2022, 58, 1–26. [Google Scholar]
  25. Lim, S.H.; Methé, B.A.; Knoll, B.M.; Morris, A.; Obaro, S.K. Invasive non-typhoidal Salmonella in sickle cell disease in Africa: Is increased gut permeability the missing link? J. Transl. Med. 2018, 16, 239. [Google Scholar] [CrossRef] [Scilit]
  26. Obeagu, E.I.; Obeagu, G.U. Managing gastrointestinal challenges: Diarrhea in sickle cell anemia. Medicine 2024, 103, e38075. [Google Scholar] [CrossRef] [Scilit]
  27. Grosse, S.D.; Odame, I.; Atrash, H.K.; Amendah, D.D.; Piel, F.B.; Williams, T.N. Sickle cell disease in Africa: A neglected cause of early childhood mortality. Am. J. Prev. Med. 2011, 41, S398–S405. [Google Scholar] [CrossRef] [Scilit]
  28. Bundy, D.G.; Strouse, J.J.; Casella, J.F.; Miller, M.R. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics 2010, 125, 234–243. [Google Scholar] [CrossRef] [Scilit]
  29. Tarry, W.F.; Duckett, J.W., Jr.; Snyder, H.M., 3rd. Urological complications of sickle cell disease in a pediatric population. J. Urol. 1987, 138, 592–594. [Google Scholar] [CrossRef] [Scilit]
  30. Barrett-Connor, E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine 1971, 50, 97–112. [Google Scholar] [CrossRef] [Scilit]
  31. Alima Yanda, A.N.; Nansseu, J.R.N.; Mbassi Awa, H.D.; Tatah, S.A.; Seungue, J.; Eposse, C.; Koki, P.O.N. Burden and spectrum of bacterial infections among sickle cell disease children living in Cameroon. BMC Infect. Dis. 2017, 17, 211. [Google Scholar] [CrossRef] [Scilit]
  32. Vichinsky, E.P.; Neumayr, L.D.; Earles, A.N.; Williams, R.; Lennette, E.T.; Dean, D.; Nickerson, B.; Orringer, E.; McKie, V.; Bellevue, R.; et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N. Engl. J. Med. 2000, 342, 1855–1865. [Google Scholar] [CrossRef] [Scilit]
Table 1. (a) Study subjects age groups (n = 1961). (b) Study subjects Hb Electrophoretic patterns (n = 1961).
Table 1. (a) Study subjects age groups (n = 1961). (b) Study subjects Hb Electrophoretic patterns (n = 1961).
(a)
Age group (years)Male (%)Female (%)Total (n = 1961)
<5387 (53.9)331 (46.1)718
5–9433 (52.0)339 (48.0)832
10–1485 (59.9)57 (40.1)142
15–1937 (49.3)38 (50.7)75
* NA112 (57.7)82(42.3)194
(b)
Hb Electrophoretic patternsMale (%)Female (%)Total (n = 1961)
SS874 (51.6)821 (48.4)1695
SC18 (64.3)10 (35.7)28
* NA134 (56.3)104 (43.7)238
* NA; not available.
Table 2. Frequency of infections (n = 458).
Table 2. Frequency of infections (n = 458).
Infection TypeCases No (%)
Malaria196 (42.8)
Osteomyelitis145 (31.6)
Acute diarrhoeal disease58 (12.7)
Acute respiratory infection34 (7.4)
Urinary trait infections25 (5.5)
Table 3. Age group and infections (n = 458).
Table 3. Age group and infections (n = 458).
Age Group (Years)No InfectionSingle InfectionMultiple InfectionsTotalChi-Sqr (df)p-Value
<5 years605 (84.3)101 (14.1)12 (1.7)718 (100)18.058 (6)0.006
5–9668 (80.3)142 (17.1)22 (2.6)832 (100)
10–14130 (91.5)11 (7.7)1 (0.7)142 (100)
15–1964 (85.3)7 (9.3)4 (5.3)75 (100)
Total1467 (83.0)261 (14.8)39 (2.2)1767 (100)
Pearson chi-square test of association and post hoc test (standardised residuals)
5–9 yrs and No infection = −2.887, 5–9 yrs and Single infection = 2.567, 10–14 yrs and No infection = 2.822,
10–14 yrs and Single infection = −2.460
Table 4. Routine immunisation and infection (n = 1904).
Table 4. Routine immunisation and infection (n = 1904).
InfectionImmunisation StatusChi-Sqr (df)p-Value
No (%)Yes (%)Total
No511 (37.6)849 (62.4)1360 (100)5.992 (1)0.014
Yes172 (31.6)372 (68.4)544 (100)
Total683 (35.9)1221 (64.1)1904 (100)
Pearson chi-square test of association
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Idris, M.A.; Ruggieri, L.; Ahmad, H.R.; Hassan, A.; Ibrahim, I.N.; Faruk, J.A.; Adebiyi, N.M.; Awwalu, S.; Usman, N.; Wada, R.; et al. Pattern of Reported Infections Among Paediatric Patients with Sickle Cell Disease: A Single-Centre Cohort Study in Nigeria. Hemato 2026, 7, 11. https://doi.org/10.3390/hemato7020011

AMA Style

Idris MA, Ruggieri L, Ahmad HR, Hassan A, Ibrahim IN, Faruk JA, Adebiyi NM, Awwalu S, Usman N, Wada R, et al. Pattern of Reported Infections Among Paediatric Patients with Sickle Cell Disease: A Single-Centre Cohort Study in Nigeria. Hemato. 2026; 7(2):11. https://doi.org/10.3390/hemato7020011

Chicago/Turabian Style

Idris, Muhammad Aminu, Lucia Ruggieri, Hafsat Rufai Ahmad, Abdulaziz Hassan, Ismaila Nda Ibrahim, Jamil Abdullahi Faruk, Niyi Mustapha Adebiyi, Sani Awwalu, Nasiru Usman, Rabiu Wada, and et al. 2026. "Pattern of Reported Infections Among Paediatric Patients with Sickle Cell Disease: A Single-Centre Cohort Study in Nigeria" Hemato 7, no. 2: 11. https://doi.org/10.3390/hemato7020011

APA Style

Idris, M. A., Ruggieri, L., Ahmad, H. R., Hassan, A., Ibrahim, I. N., Faruk, J. A., Adebiyi, N. M., Awwalu, S., Usman, N., Wada, R., Muhammad, M., Abdulkadir, S., Bonifazi, F., Atoyebi, W., & Inusa, B. P. D. (2026). Pattern of Reported Infections Among Paediatric Patients with Sickle Cell Disease: A Single-Centre Cohort Study in Nigeria. Hemato, 7(2), 11. https://doi.org/10.3390/hemato7020011

Article Metrics

Back to TopTop